Deutsche Bank AG Lowers Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)

Deutsche Bank AG is a multinational investment bank and financial services company headquartered in Frankfurt, Germany. The company operates in various segments, including corporate banking, investment banking, asset management, and private wealth management.

Arcturus Therapeutics Holdings Inc. NASDAQARCT is a biotechnology company based in San Diego, California, USA. The company focuses on developing and commercializing gene therapy products for the treatment of rare genetic diseases.

According to Deutsche Bank's most recent disclosure with the Securities & Exchange Commission (SEC), the institutional investor reduced its position in shares of Arcturus Therapeutics Holdings Inc. NASDAQARCT by 19.0% during the third quarter. This means that after selling 7,160 shares, Deutsche Bank now owns 30,426 shares of the biotechnology company's stock.

It is important to note that this information is based on publicly available disclosures and may not reflect the current position of Deutsche Bank or any other institutional investor in Arcturus Therapeutics Holdings Inc. NASDAQARCT. It is always recommended to consult with a financial advisor before making any investment decisions.